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 BACKGROUND 
 Congenital deﬁ ciency of factor X is a rare autosomal reces-
sive bleeding disorder with an incidence of 1:1 000 000 in 
the general population. 1  2 An acquired factor X deﬁ cit in 
children with a normal homeostasis is an even rarer situ-
ation, and most cases are associated with systemic amy-
loidosis. 3 The acquired form also appears sporadically in 
patients with respiratory mycoplasma infection, vitamin K 
deﬁ ciency/liver disease and during the use of certain medi-
cations (valproic acid, topical thrombin). 4 – 6 In paediatric 
burn victims, three cases of transient factor X deﬁ ciency 
are described: one due to the presence of an inhibitor, 7 
another associated with anti-cardiolipin antibody 8 and the 
third apparently related to meropenem use. 9 The patho-
genesis and transient nature of this deﬁ ciency remain 
poorly understood. The authors present a case of a teen-
ager with extensive burns who later developed bleeding 
due to lack of factor X. 
 CASE PRESENTATION 
 We report the case of a 16-year-old adolescent, admitted to 
the Pediatric Intensive Care Unit (PICU) due to a high-volt-
age electrical burn (railroad tracks), with 80% of total body 
surface area (TBSA) (head, face, feet and the distal left leg 
spared). His family and personal history were negative, 
especially with regards to a history of bleeding disorder. 
After initial stabilisation with intravenous ﬂ uids, topical 
therapy with silver sulfadiazine was initiated. Given the 
extent of burns, deep sedation and mechanical ventila-
tion were initiated and maintained for 6 days without 
complications. On the second day of hospitalisation (D2) 
he underwent surgical debridement without the need of 
transfusion therapy, and alternate-day silver sulfadiazine 
dressings were maintained. Due to maintenance of hypo-
tension after expansion with saline, inotropic support was 
started (dopamine and epinephrine). On D3, due to devel-
opment of high fever and elevation of C reactive protein 
(370 mg/l), antibiotic therapy with ﬂ ucloxacillin (2 g, 6/6 h, 
for 21 days) and gentamicin (14 days) was instituted. Blood 
cultures were negative. The coagulation results at this stage 
showed no alterations – thrombin time (PT) 12.1 s, interna-
tional normalised ratio (INR) 1.1 and partial thromboplastin 
time (APTT) 33 s. Haemodynamic stability was achieved 
progressively, and inotropes were suspended on D8. On 
D9, venous thromboembolism prophylaxis with enoxa-
parin and acetylsalicylic acid was initiated. His remaining 
stay in the PICU progressed favourably and uneventfully 
from a clinical standpoint. In terms of laboratory results, on 
D18, a good outcome was conﬁ rmed, with haemoglobin 
9.3 mg/dl, leucocytes 18 470/μl with 76.9% neutrophils, C 
reactive protein of 4.4 mg/dl, PT 13.1 s, APTT 30.5 s, INR 
1.1, ﬁ brinogen 227.2 mg/dl (154–488),  D -dimer 178 (<250) 
and absence of ﬁ brin degradation products. 
 After 22 days of hospitalisation in the PICU, given 
the good clinical outcome and after stopping antibiot-
ics, he was transferred to the Pediatric Surgery ward. On 
D23, after removal of a central venous catheter, abundant 
bleeding was noted, controlled by local compression. 
Thromboembolism prophylaxis was immediately discon-
tinued. Concomitantly, a transient (48-h duration) macu-
lopapular, non-pruriginous rash was noted, which after 
Immunoallergology consult was interpreted as an irritant 
dermatitis and treated with hydroxyzine. 
 INVESTIGATIONS 
 At this time, the laboratory evaluation revealed no altera-
tions signiﬁ cant for bacterial infection (leucocytes 11 000/
μl; neutrophils 59.2%; 484 000 platelets/ml; C reactive pro-
tein 35.4 mg/l), but signiﬁ cant coagulation changes were 
demonstrated (PT 28.1 s, INR 2.40, APTT 38.8 s). 
 Clinically, there were no signs of disseminated intravas-
cular coagulation. 
 A summary examination of the urine showed micro-
scopic haematuria (erythrocyturia 3+). The liver function 
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 Acquired factor X defi ciency is an extremely rare situation. It has shown to be associated with systemic amyloidosis, respiratory mycoplasma 
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tests were normal. Factor X measurement showed greatly 
decreased values (10% – normal value between 60% and 
150%). A plasma-mixing test was performed with normal-
isation of plasma coagulation tests, ruling out the presence 
of an inhibitor. 
 OUTCOME AND FOLLOW-UP 
 By D32, both coagulation studies (PT 11.8 s, INR 1.3, APTT 
31.5 s) and the measurement of factor X were normal. The 
patient suffered no further episodes of bleeding disorder. 
 DISCUSSION 
 Patients with major burns develop a tendency towards 
hypercoagulability, and prophylactic anticoagulant ther-
apy was used earlier. In these patients, bleeding disorders 
may be associated with severe infection or disseminated 
intravascular coagulation. Acquired factor X deﬁ ciency is 
extremely rare with few cases reported in the literature. 
This factor plays a central role in the coagulation cascade, 
justifying the concomitant changes in APTT and PT (INR). 
Symptoms related to the factor X deﬁ ciency depend on its 
serum concentration – values between 1% and 10% are 
associated with minor bleeding, especially during surgi-
cal procedures, or, as was the case with our patient, on 
removal of a central intravenous catheter. Severe bleeding 
is described when values fall below 1%. 9 In the present 
case, despite the absence of fever, signiﬁ cant inﬂ ammatory 
markers or positive blood cultures, an initial diagnosis of 
infection, was entertained. After factor X deﬁ ciency was 
conﬁ rmed, the most frequent causes were systematically 
excluded. Systemic amyloidosis was highly unlikely given 
the presence of a previously healthy child. A respiratory 
mycoplasma infection was rejected given the absence of 
respiratory symptoms. Vitamin K deﬁ ciency or liver dis-
eases, other possible causes, were also rejected because 
they usually present with associated deﬁ cits of other 
coagulation factors. In addition, liver function tests were 
normal. The presence of acquired inhibitors of coagulation 
factors in children with normal haemostasis is rare. There 
are two cases reported in paediatric burn victims where 
the factor X deﬁ ciency results from the presence of inhibi-
tors. 7  8 The plasma-mixing test, with resultant normalisa-
tion of PT and APTT, contradicted this hypothesis. 
 In our case, the hypothesis of haemorrhage secondary 
to anticoagulant therapy was also placed, and this therapy 
was immediately suspended. However, antithromboem-
bolic prophylaxis cannot explain the observed bleeding dis-
order because the low molecular weight heparins (HBPM) 
do not interfere with the PT and APTT. 10 
 Previous studies report problems in correcting bleeding 
disorders caused by the factor X deﬁ ciency, requiring fresh 
frozen plasma and prothrombin complex. In our patient, 
the minor bleeding and a benign outcome observed were 
mainly due to the fact that the factor X deﬁ cit was moder-
ate (10%), as most cases described in the literature have 
values less than 1%. 
 Jennes  et al describe a case of transient factor X deﬁ ciency 
in a 12-month-old child with extensive burns, apparently 
associated with meropenem use. Other medications have 
also been implicated, such as valproic acid and topical 
thrombin. 5  6 In the described case, the antibiotic had been 
suspended on the eve of the bleeding episode and there-
fore could not exclude cause–effect relationship. 
 In conclusion, our case study is due to a transient deﬁ -
ciency of factor X, possibly associated with ﬂ ucloxacillin. 
In fact, in the previously described three cases, the bleed-
ing disorder also did not develop in the time-span imme-
diately after burn, in which more complications are to be 
expected, but between 15 and 19 days of hospitalisation. 
Further studies of factor X levels in burn patients will have 
to be conducted to better understand this relationship. 
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Learning points
 Acquired factor X defi ciency is extremely rare.  ▶
 In paediatric burn victims, three cases of transient  ▶
factor X defi ciency are described: one due to the 
presence of an inhibitor, another associated with 
anticardiolipin antibody and the third apparently related 
to meropenem use. 
 We report a transient defi ciency of factor X in a  ▶
teenager with extensive burns possibly associated with 
fl ucloxacillin. 
 The pathogenesis and transient nature of this defi ciency  ▶
remain poorly understood. 
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